Incannex Healthcare (IXHL) Interest & Investment Income (2022 - 2025)
Incannex Healthcare (IXHL) posted Interest & Investment Income of $2000.0 for Q2 2025, down 50.0% sequentially from $4000.0 in Q1 2025, and down 95.0% YoY from $40000.0 in Q2 2024.
Incannex Healthcare (IXHL) Interest & Investment Income (2022 - 2025) Analysis & Trends
Incannex Healthcare has reported Interest & Investment Income for 4 years, with the latest figure at $2000.0 in Q2 2025.
- Quarterly Interest & Investment Income fell 95.0% year-over-year to $2000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $62000.0 (down 69.9% YoY) and the FY2025 annual result came in at $62000.0, down 69.9% from the prior year.
- Interest & Investment Income fell to $2000.0 in Q2 2025 per IXHL's latest filing, from $4000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $163000.0 in Q1 2023 and troughed at $2000.0 in Q2 2025.
- A 4-year average of $52181.8 and a median of $40000.0 in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2024 and 2025: Interest & Investment Income soared 40.0% in 2024, then sank 95.0% in 2025.
- Over 4 years, Interest & Investment Income stood at $55000.0 in 2022, then plunged by 63.64% to $20000.0 in 2023, then jumped by 40.0% to $28000.0 in 2024, then sank by 92.86% to $2000.0 in 2025.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $2000.0, $4000.0, and $28000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Incannex Healthcare | 41.37 Mn | 41.37 Mn | - | 6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | 28,000.00 |
| Jun 30, 2024 | 40,000.00 |
| Mar 31, 2024 | 75,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Sep 30, 2023 | 71,000.00 |
| Jun 30, 2023 | 88,000.00 |
| Mar 31, 2023 | 163,000.00 |
| Dec 31, 2022 | 55,000.00 |